Skip to main content
SpringerLink
Log in

Pharmacokinetic Drug Interactions with Phenytoin (Part II)

  • Pharmacokinetic Drag Interactions
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Abstract

Part I of this article, which appeared in the previous issue of the Journal, covered the drug interactions affecting the pharmacokinetics of phenytoin. The influence of phenytoin on the gastrointestinal absorption and plasma protein binding of other drugs was also discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ahmad S. Renal insensitivity to frusemide caused by chronic anticonvulsanl therapy. British Medical Journal 3: 657–659, 1974

    Article  PubMed  CAS  Google Scholar 

  • Ahmad S. Ticrynafen-induced phenytoin toxicity: an interaction. Journal of the Royal Society of Medicine 74: 162–163, 1981

    PubMed  CAS  Google Scholar 

  • Ahmad S. Nifedipine-phenyloin interaction. Journal of the American College of Cardiology 3: 1582, 1984

    Article  PubMed  CAS  Google Scholar 

  • Aitio ML, Mansury L, Tala E, Haataja M, Aitio A. The effect of enzyme induction on the metabolism of disopyramide in man. British Journal of Clinical Pharmacology 11: 279–285, 1981

    Article  PubMed  CAS  Google Scholar 

  • Aitio ML, Vuorenmaa T. Enhanced metabolism and diminished efficacy of disopyramide by enzyme induction? British Journal of Clinical Pharmacology 9: 149–152, 1980

    Article  PubMed  CAS  Google Scholar 

  • Alexanderson B, Evans DAP, Sjoqvist F. Steady state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy. British Medical Journal 4: 764–768, 1969

    Article  PubMed  CAS  Google Scholar 

  • Algozzine GJ, Stewart RB, Springer PK. Decreased clearance of phenytoin with cimetidine. Annals of Internal Medicine 95: 244–245, 1981

    PubMed  CAS  Google Scholar 

  • Andreasen PB, Froland A, Skovsted L, Andersen SA, Hauge M. Diphenylhydantoin half-life in man and its inhibition by phenylbutazone: the role of genetic factors. Acta Medica Scandinavica 193: 561–564, 1973

    Article  PubMed  CAS  Google Scholar 

  • Andreasen PB, Hansen JM, Skovsted L, Siersbaek-Nielsen K. Folic acid and the half-life of diphenylhydantoin in man. Acta Neurologica Scandinavica 47: 117–119, 1971

    Article  PubMed  CAS  Google Scholar 

  • Bachmann K.A, Schwartz Jl, Forney RB, Jauregui L. Single dose phenytoin clearance during erythromycin treatment. Research Communications in Chemical Pathology and Pharmacology 46: 207–217, 1984

    PubMed  CAS  Google Scholar 

  • Bachmann KA, Schwartz Jl, Forney RB, Jauregui L, Sullivan TJ. Inability of ibuprofen to alter single dose phenytoin disposition. British Journal of Clinical Pharmacology 21: 165–169, 1986

    Article  PubMed  CAS  Google Scholar 

  • Back DJ, Bates M, Bowden A, Breckenridge AM, Hall MJ, et al. The interaction of phenobarbital and other anticonvulsants with oral contraceptive steroid therapy. Contraception: 22: 495–503, 1980

    Article  PubMed  CAS  Google Scholar 

  • Ballek RE, Reidenberg MM, Orr L. Inhibition of diphenylhydantoin metabolism by chloramphenicol. Lancet I: 150, 1973

    Article  Google Scholar 

  • Baranetsky NG, Chertow BS, Webb MD, Leonard RF, Sivitz WI. Combined phenytoin and salicylate effects on thyroid function tests. Archives Internationales de Pharmacodynamie et de Thérapie 284: 166–176, 1986

    PubMed  CAS  Google Scholar 

  • Barkfeldt JO, Odlind V, Victor A. Interaction between phenytoin and norethisterone in the rhesus monkey. Contraception 27: 423–429, 1983

    Article  PubMed  CAS  Google Scholar 

  • Bartle WR, Walker SE, Shapero T. Dose-dependent effect of cimetidine on phenytoin kinetics. Clinical Pharmacology and Therapeutics 33: 649–655, 1983

    Article  PubMed  CAS  Google Scholar 

  • Battino D, Bossi L, Croci D, Franceschetti S, Ilonian C. Carbamazepine plasma levels in children and adults: influence of age, dose, and associated therapy. Therapeutic Drug Monitoring 2: 315–322, 1980

    PubMed  CAS  Google Scholar 

  • Bauer LA. Interference of oral phenytoin absorption by continuous nasogastric feedings. Neurology 32: 570–572, 1982

    Article  PubMed  CAS  Google Scholar 

  • Baylis EM, Crowley JM, Preece JM, Sylvester PE, Marks V. Influence of folic acid on blood-phenytoin levels. Lancet 1: 62–64, 1971

    Article  PubMed  CAS  Google Scholar 

  • Begg EJ, Chinwah PM, Webb C, Day RO, Wade DN. Enhanced metabolism of mexiletine after phenytoin administration. British Journal of Clinical Pharmacology 14: 219–223, 1982

    Article  PubMed  CAS  Google Scholar 

  • Berg MJ, Ebert BE, Rivey MP, Schottelius DD. Utilization of Km for phenytoin dosage after folate addition to patient regimen. Therapeutic Drug Monitoring 9: 304–305, 1987

    Article  PubMed  CAS  Google Scholar 

  • Berg MJ, Fischer LJ, Rivey MP, Vern BA, Lantz RK. Phenytoin and folic acid interaction: a preliminary report. Therapeutic Drug Monitoring 5: 389–394, 1983a

    Article  PubMed  CAS  Google Scholar 

  • Berg MJ, Rivey MP, Vern BA, Fischer LJ, Schottelius DD. Phenytoin and folic acid: individualized drug-drug interaction. Therapeutic Drug Monitoring 5: 395–399, 1983b

    Article  PubMed  CAS  Google Scholar 

  • Bianchetti G, Padovani P, Thenot JP, Thiercelin JF, Morselli PL. Pharmacokinetic interactions of progabide with other antiepileptic drugs. Epilepsia 28: 68–73, 1987

    Article  PubMed  CAS  Google Scholar 

  • Birkett DJ, Miners JO, McManus ME, Stupans I, Veronese ME. el al. Theophylline and tolbulamidc as model substrates for cytochrome P-450 isozymes in animals and man. In Miners et al. (Eds) Microsomes and drug oxidations, pp. 241–251, Taylor and Francis, London, 1988

    Google Scholar 

  • Blackshear JL, Schultz AL, Napier JS, Stuart DD. Thyroxine replacement requirements in hypothyroid patients receiving phenytoin. Annals of Internal Medicine 99: 341–342, 1983

    PubMed  CAS  Google Scholar 

  • Blyden GT, Scavone JM, Greenblatt DJ. Metronidazole impairs clearance of phenytoin but not of alprazolam or lorazepam. Journal of Clinical Pharmacology 28: 240–245, 1988

    PubMed  CAS  Google Scholar 

  • Bollini P, Riva R, Albani F, Ida N, Cacciara L, et al. Decreased phenytoin levels during antineoplastic therapy: A case report. Epilepsia 24: 75–78, 1983

    Article  PubMed  CAS  Google Scholar 

  • Borga O, Azarnoff DL, Forshell GP, Sjoqvist F. Plasma protein binding of tricyclic antidepressants in man. Biochemical Pharmacology 18: 2135–2143, 1969

    Article  PubMed  CAS  Google Scholar 

  • Braithwaite RA, Flanagan RJ. Steady-state plasma nortriptyline concentrations in epileptic patients. British Journal of Clinical Pharmacology 2: 469–471, 1975

    Article  PubMed  CAS  Google Scholar 

  • Bramhall D, Levine M. Possible interaction of ranitidine with phenytoin. Drug Intelligence and Clinical Pharmacy 22: 979–980, 1988

    PubMed  CAS  Google Scholar 

  • Brennan RW, Dehejia H, Kutt H, Verebely K, McDowell F. Diphenylhydantoin intoxication attendant to slow inactivation of isoniazid. Neurology 20: 687–693, 1970

    Article  PubMed  CAS  Google Scholar 

  • Brown CG, Kaminsky MJ, Feroli ER, Gurley HT. Delirium with phenytoin and disulfiram administration. Annals of Emergency Medicine 12: 310–313, 1983

    Article  PubMed  CAS  Google Scholar 

  • Browne TR, Szabo GK, Evans J, Evans BA, Greenblatt DJ, et al. Phenobarbital does not alter phenytoin steady-state serum concentration or pharmacokinetics. Neurology 38: 639–642, 1988a

    Article  PubMed  CAS  Google Scholar 

  • Browne TR, Szabo GK, Evans JE, Evans BA, Greenblatt DJ, el al. Carbamazepine increases phenytoin serum concentration and reduces phenytoin clearance. Neurology 38: 1146–1150, 1988b

    Article  PubMed  CAS  Google Scholar 

  • Bruni J, Gallo JM, Lee CS, Perchalski RJ, Wilder BJ. Interactions of valproic acid with phenytoin. Neurology 30: 1233–1236, 1980

    Article  PubMed  CAS  Google Scholar 

  • Cacek AT, DeVito JM, Koonce JR. In vitro evaluation of nasogastric administration methods for phenytoin. American Journal of Hospital Pharmacy 43: 689–692, 1986

    PubMed  CAS  Google Scholar 

  • Caille G, Souich PD, Lariviere L, Vezina M, Lacasse Y. The effect of administration of phenytoin on the pharmacokinetics of isoxicam. Biopharmaceutics and Drug Disposition 8: 57–61, 1987

    Article  CAS  Google Scholar 

  • Callaghan JT, Tsuru M, Holtzman JL, Hunninghake DB. Effect of cholestyramine and colestipol on the absorption of phenytoin. European Journal of Clinical Pharmacology 24: 675–678, 1983

    Article  PubMed  CAS  Google Scholar 

  • Callaghan N, Feely M, Duggan F, O’Callaghan M, Seldrup J. The effect of anticonvulsant drugs which induce liver microsomal enzymes on derived and ingested phenobarbitone levels. Acta Neurologica Scandinavica 56: 1–6, 1977

    Article  PubMed  CAS  Google Scholar 

  • Canafax DM, Ascher NI. Cyclosporine immunosuppression. Clinical Pharmacy 2: 515–524, 1983

    PubMed  CAS  Google Scholar 

  • Carter BL, Garnett WR, Pellock JM, Stratton MA, Howell JR. Effect of antacids on phenytoin bioavailabilily. Therapeutic Drug Monitoring 3: 333–340, 1981

    Article  PubMed  CAS  Google Scholar 

  • Cereghino JJ, Brock JT, Van Meter JC, Penry JK, Smith LD, et al. The efficacy of carbamazepine combinations in epilepsy. Clinical Pharmacology and Therapeutics 18: 733–741, 1975

    PubMed  CAS  Google Scholar 

  • Chalk JB, Ridgeway K, Brophy TRO’R, Yelland JDN, Eadie MJ. Phenytoin impairs the bioavailabilily of dexamethasone in neurological and neurosurgical patients. Journal of Neurology, Neurosurgery, and Psychiatry 47: 1087–1090, 1984

    Article  PubMed  CAS  Google Scholar 

  • Chang T, Glazko AJ. Phenytoin biotransformation. In Woodbury et al. (Eds) Antiepileptic drugs. 2nd ed., pp. 209–226, Raven Press, New York, 1982

    Google Scholar 

  • Chapron DJ, Kramer PA, Mariano SL, Hohnadel DC. Effect of calcium and antacids on phenytoin bioavailability. Archives of Neurology 36: 436–438, 1979

    Article  PubMed  CAS  Google Scholar 

  • Choi Y, Thrasher K, Werk EE, Sholiton LJ, Olinger C. Effect of diphenylhydantoin on cortisol kinetics in humans. Journal of Pharmacology and Experimental Therapeutics 176: 27–34, 1971

    PubMed  CAS  Google Scholar 

  • Christensen LK, Skovsted L. Inhibition of drug metabolism by chloramphenicol. Lancet 2: 1397–1399, 1969

    Article  PubMed  CAS  Google Scholar 

  • Christiansen J, Dam M. Influence of phenobarbital and diphenylhydantoin on plasma carbamazepine levels in patients with epilepsy. Acta Neurologica Scandinavica 49: 543–546, 1973

    Article  PubMed  CAS  Google Scholar 

  • Cloyd JC, Miller KW, Leppik IE. Primidone kinetics: effects of concurrent drugs and duration of therapy. Clinical Pharmacology and Therapeutics 29: 402–407, 1981

    Article  PubMed  CAS  Google Scholar 

  • Cosh DG, Rowett DS, Lee PC, McCarthy PJ. Case report -phenytoin therapy complicated by concurrent chloramphenicol and enterai nutrition. Australian Journal of Hospital Pharmacy 17: 51–53, 1987

    Google Scholar 

  • Coulam CB, Annegers JF. Do anticonvulsants reduce the efficacy of oral contraceptives? Epilepsia 20: 519–526, 1979

    Article  PubMed  CAS  Google Scholar 

  • Cramer JA, Matlson RH. Valproic acid: in vitro plasma protein binding and interaction with phenytoin. Therapeutic Drug Monitoring 1: 105–116, 1979

    Article  PubMed  CAS  Google Scholar 

  • Crawford P, Chadwick D. A comparative study of progabide, valproate, and placebo as add-on therapy in patients with refractory epilepsy. Journal of Neurology. Neurosurgery, and Psychiatry 49: 1251–1257, 1986

    CAS  Google Scholar 

  • Crowley JJ, Cusack BJ, Jue SG, Koup JR, Park BK, et al. Aging and drug interactions. II. Effect of phenytoin and smoking on the oxidation of theophylline and conisol on healthy men. Journal of Pharmacology and Experimental Therapeutics 245: 513–523, 1988

    PubMed  CAS  Google Scholar 

  • Crowley JJ, Cusack BJ, Jue SG, Koup JR, Vestal RE. Cigarette smoking and theophylline metabolism: effects of phenytoin. Clinical Pharmacology and Therapeutics 42: 334–340, 1987

    Article  PubMed  CAS  Google Scholar 

  • Cucinell SA, Conney AH, Sansur M, Burns JJ. Drug interactions in man. I. Lowering effect of phenobarbital on plasma levels of bishydroxycoumann (Dicumarol) and diphenylhydantoin (Dilantin). Clinical Pharmacology and Therapeutics 6: 420–429, 1965

    PubMed  CAS  Google Scholar 

  • Cunningham JL, Evans DAP. Urinary D-glucaric acid excretion and acetanilide pharmacokinetics before and during diphen-ylhydamoin administration. European Journal of Clinical Pharmacology 7: 387–391, 1974

    Article  PubMed  CAS  Google Scholar 

  • Cunningham JL, Evans DAP. Acetanilide and paracetamol pharmacokinetics before and during phenytoin administration: genetic control of induction? British Journal of Clinical Pharmacology 11: 591–595, 1981

    Article  PubMed  CAS  Google Scholar 

  • Dahlqvist R, Borga O, Rane A, Walsh Z, Sjoqvist F. Decreased plasma protein binding of phenytoin in patients on valproic acid. British Journal of Clinical Pharmacology 8: 547–552, 1979

    Article  PubMed  CAS  Google Scholar 

  • Dam M, Gram L, Philbert A, Hansen BS, Lyon BB, el al. Progabide: a controlled trial in partial epilepsy. Epilepsia 24: 127–134, 1983

    Article  PubMed  CAS  Google Scholar 

  • Dam M, Jensen A, Christiansen J. Plasma level and effect of carbamazepine in grand mal and psychomotor epilepsy. Acta Neu-rologica Scandinavica 60(Suppl): 33–38, 1975

    Article  CAS  Google Scholar 

  • D’Arcy PF, McElnay JC. Drug-antacid interactions: assessment of clinical importance. Drug Intelligence and Clinical Pharmacy 21: 607–617, 1987

    PubMed  Google Scholar 

  • Data JL, Wilkinson GR, Nies AS. Interaction of quinidine with anticonvulsant drugs. New England Journal of Medicine 294: 699–702, 1976

    Article  PubMed  CAS  Google Scholar 

  • De Leacy EA, McLeay CD, Eadie MJ, Tyrer JH. Effects of subject’ sex, and intake of tobacco, alcohol and oral contraceptives on plasma phenytoin levels. British Journal of Clinical Pharmacology 8: 33–36, 1979

    Article  PubMed  Google Scholar 

  • Dische S, Saunders Ml, Lee ME, Adams GE, Flockhan IR. Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses. British Journal of Cancer 35: 567–579, 1977

    Article  PubMed  CAS  Google Scholar 

  • Dorn JM. A case of phenytoin toxicity possibly precipated by trazodone. Journal of Clinical Psychiatry 47: 89–90, 1986

    PubMed  CAS  Google Scholar 

  • D’Souza MJ. Pollock SH. Solomon HM. Cyclosporine-phenytoin interaction. Drug Metabolism and Disposition 16: 256–258 1988

    PubMed  Google Scholar 

  • Editorial. Drug interaction with oral contraceptive steroids. British Medical Journal 281: 93–94, 1980

    Article  Google Scholar 

  • Elias AN. Gwinup G. Effects of some clinically encountered drugs on steroid synthesis and degradation. Metabolism 29: 582–595 1980

    Article  PubMed  CAS  Google Scholar 

  • Evans AM, Nation RL, Sansom LN, Bochner F, Somogyi A.A. Stereoselective drug disposition: potential for misinterpretation of unresolved drug disposition data. British Journal of Clinical Pharmacology 26: 771–780, 1988

    Article  PubMed  CAS  Google Scholar 

  • Evans PJ, Walker RF, Peters JR, Dyas J, Riad-Fahmy D, el al. Anticonvulsant therapy and cortisol elimination. British Journal of Clinical Pharmacology 20: 129–132, 1985

    Article  PubMed  CAS  Google Scholar 

  • Faber J, Lumholtz IB, Kirkegaard C, Poulsen S. The effects of phenytoin (diphenylhydantoin) on the extrathyroidal turnover of thyroxine. 3.5.3′-triiodothyronine. 3.3’.5’-triiodothyronine, and 3′.5′-diiodothyronine in man. Journal of Clinical Endocrinology and Metabolism 61: 1093–1099, 1985

    Article  PubMed  CAS  Google Scholar 

  • Fernandez MC, Erill S, Lucena Ml, Pita E, Perez-Alferez N. Serum protein binding of tolbutamide in patients treated with antiepileptic drugs. Clinical Pharmacokinetics 10: 451–455, 1985

    Article  PubMed  CAS  Google Scholar 

  • Fichman MP, Kleeman CR, Bethune JE. Inhibition of antidiuretic hormone secretion by diphenylhydantoin. Archives of Neurology 22: 45–53, 1970

    Article  PubMed  CAS  Google Scholar 

  • Fincham RW, Schottelius DD. Decreased phenytoin levels in antineoplastic therapy. Therapeutic Drug Monitoring 1: 277–283, 1979

    Article  PubMed  CAS  Google Scholar 

  • Fincham RW, Schottelius DD, Sahs AL. The influence of diphenylhydantion on primidone metabolism. Archives of Neurology 30: 259–262, 1974

    Article  PubMed  CAS  Google Scholar 

  • Fincham RW, Wiley DE, Schottelius DD. Use of phenytoin serum levels in a case of status epilepticus. Neurology 26: 879–881, 1976

    Article  PubMed  CAS  Google Scholar 

  • Fine A, Henderson S, Morgan R. Malabsorption of frusemide caused by phenytoin. British Medical Journal 2: 1061–1062, 1977

    Article  PubMed  CAS  Google Scholar 

  • Finelli PF. Phenytoin and methadone tolerance. New England Journal of Medicine 294: 227, 1976

    PubMed  CAS  Google Scholar 

  • Fogel BS, Haltzman S. Desipramine and phenytoin: a potential drug interaction of therapeutic relevance. Journal of Clinical Psychiatry 48: 387–389, 1987

    PubMed  CAS  Google Scholar 

  • Fraser DG, Ludden TM, Evens RP, Sutherland EW. Displacement of phenytoin from plasma binding sites by salicyclate. Clinical Pharmacology and Therapeutics 27: 165–169, 1980

    Article  PubMed  CAS  Google Scholar 

  • Freeman DJ, Laupacis A, Keown PA, Stiller CR, Carruthers SG. Evaluation of cyclosporin-phenytoin interaction with observations on cyclosporin metabolites. British Journal of Clinical Pharmacology 18: 887–893, 1984

    Article  PubMed  CAS  Google Scholar 

  • Frey BM, Frey FJ. Phenytoin modulates the pharmacokinetics of prednisolone and the pharmacodynamics of prednisolone as assessed by the inhibition of the mixed lymphocyte reaction in humans. European Journal of Clinical Investigation 14: 1–6, 1984

    Article  PubMed  CAS  Google Scholar 

  • Frey FJ, Frey BM. Urinary 6β-hydroxyprednisolone excretion indicates enhanced prednisolone catabolism. Journal of Laboratory and Clinical Medicine 101: 593–604, 1983

    PubMed  CAS  Google Scholar 

  • Frigo GM, Lecchini S, Caravaggi M, Gatti G, Tonini M, et al. Reduction in phenytoin clearance caused by cimetidine. European Journal of Clinical Pharmacology 25: 135–137, 1983

    Article  PubMed  CAS  Google Scholar 

  • Fritz S, Lindner W, Roots I, Frey BM, Kupfe A. Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation phenotypes in humans. Journal of Pharmacology and Experimental Therapeutics 241: 615–622, 1987

    PubMed  CAS  Google Scholar 

  • Fuerst RH, Graves NM, Leppik IE, Brundage RC, Holmes GB, et al. Felbamate increases phenytoin but decreases carbamazepine concentrations. Epilepsia 29: 488–491, 1988

    Article  PubMed  CAS  Google Scholar 

  • Furlanut M, Benetello P, Avogaro A, Dainese R. Effects of folic acid on phenytoin kinetics in healthy subjects. Clinical Pharmacology and Therapeutics 24: 294–297, 1978

    PubMed  CAS  Google Scholar 

  • Gambertoglio JG, Holford NHG, Kapusnik JE, Nishikawa R, Saltiel M, et al. Disposition of total and unbound prednisolone in renal transplant patients receiving anticonvulsants. Kidney International 25: 119–123, 1984

    Article  PubMed  CAS  Google Scholar 

  • Gangji D, Schwade JG, Strong JM. Phenytoin-misonidazole: possible metabolic interaction. Cancer Treatment Reports 64: 155–156, 1980

    PubMed  CAS  Google Scholar 

  • Garnett WR, Carter BL, Pellock JM. Bioavailability of phenytoin administered with antacids. Therapeutic Drug Monitoring 1: 435–437, 1979

    Article  Google Scholar 

  • Garnett WR, Carter BL. Pellock JM. Effect of calcium and antacids on phenytoin bioavailability. Archives of Neurology 37: 467. 1980

    Article  PubMed  CAS  Google Scholar 

  • Garrettson LK, Gomez M. Phenytoin-primidone interaction. British Journal of Clinical Pharmacology 4: 693–695, 1977

    Article  Google Scholar 

  • Garrettson LK, Perel JM, Dayton PG. Melhylphenidate interaction with both anticonvulsants and ethyl biscoumacetate. Journal of the American Medical Association 207: 2053–2056, 1969

    Article  PubMed  CAS  Google Scholar 

  • Geaney DP. Carver JG, Aronson JK. Interaction of azapropazone with phenytoin. British Medical Journal 284: 1373. 1982

    Article  PubMed  CAS  Google Scholar 

  • Geaney DP, Carver JG, Davies CL, Aronson JK. Pharmacokinetic investigation of the interaction of azapropazone with phenytoin. British Journal of Clinical Pharmacology 15: 727–734, 1983

    Article  PubMed  CAS  Google Scholar 

  • Gillman MA, Sandyk R. Phenytoin toxicity and co-trimoxazole. Annals of Internal Medicine 102: 559. 1985

    PubMed  CAS  Google Scholar 

  • Glazko AJ. Antiepileplic drugs: biotransformation, metabolism, and serum half-life. Epilepsia 16: 367–391, 1975

    Article  PubMed  CAS  Google Scholar 

  • Gore JM. Haffajee CI. Alpert JS. Interaction of amiodarone and diphenylhydantoin. American Journal of Cardiology 54: 1145. 1984

    Article  PubMed  CAS  Google Scholar 

  • Gotz VP, Yost RL, Lamadrid ME, Buchanan CD. Evaluation of a potential interaction: thioridazine-phenytoin — negative findings. Hospital Pharmacy 19: 555–557, 1984

    Google Scholar 

  • Grau ES. Theodore WH. Newmark ME. Kupferberg HJ. Porter RJ. et al. Effect of carbamazepine on phenytoin clearance in patients with complex partial seizures. Neurology 32: A223. 1982

    Google Scholar 

  • Graves NM, Holmes GB, Fverst RH, Leppik IE. Effect of fel-bamate on phenytoin and carbamazepine serum concentrations. Epilepsia 30: 225–229, 1989

    Article  PubMed  CAS  Google Scholar 

  • Greendyke RM, Gulya A. Effect of pindolol administration on serum levels of thioridazine, haloperidol, phenytoin, and phenobarbital Journal of Clinical Psychiatry 49: 105–107, 1988

    CAS  Google Scholar 

  • Gugler R, Jensen JC. Omeprazole inhibits oxidalive drug metabolism. Gastroenterology 89: 1235–1241, 1985

    PubMed  CAS  Google Scholar 

  • Habcner JF, Mahaffey JE. Osteomalacia and disorders of vitamin D metabolism. Annual Reviews of Medicine 29: 327–342, 1978

    Article  Google Scholar 

  • Halawa B. Quinidine sulphate interactions with propranolol, phenytoin, verapamil and procainamide. Polski Tygodnik Lekarski 39: 823–826, 1984

    PubMed  CAS  Google Scholar 

  • Halawa B. Phenytoin interactions with propranolol, procainamide and digoxin. Polski Tygodnik Lekarski 40: 790–793, 1985

    PubMed  CAS  Google Scholar 

  • Hall TG, Cuddy PG, Glass CJ, Melethil S. Effect of sucralfate on phenytoin bioavailability. Drug Intelligence and Clinical Pharmacy 20: 607–611, 1986

    PubMed  CAS  Google Scholar 

  • Hannah DM, Sprunt JG. The quantitation of melyrapone and its reduced derivative in urine. Journal of Pharmacy and Pharmacology 21: 877–878, 1969

    Article  PubMed  CAS  Google Scholar 

  • Hansen BS, Dam M, Brandt J, Hvidberg EF, Angelo H, et al. Influence of dextropropoxyphene on steady state serum levels and protein binding of three anti-epileptic drugs in man. Acta Neurologica Scandinavica 61: 357–367, 1980

    Article  PubMed  CAS  Google Scholar 

  • Hansen JM, Kampmann JP, Siersbaek-Nielson K, Lumholtz IB, Arroe M, et al. The effect of different sulfonamides on phenytoin metabolism in man. Acta Medica Scandinavica (Suppl.) 624: 106–110, 1979

    CAS  Google Scholar 

  • Hansen JM, Kristensen M, Skovsted L. Sulthiame (Ospolot®) as inhibitor of diphenylhydantoin metabolism. Epilepsia 9: 17–22, 1968

    Article  PubMed  CAS  Google Scholar 

  • Hansen JM, Kristensen M, Skovsted L, Christensen LK. Dicoumarol-induced diphenylhydantoin intoxication. Lancet 2: 265–266, 1966

    Article  PubMed  CAS  Google Scholar 

  • Hansen JM, Siersbaek-Nielsen K, Kristensen M, Skovsted L, Christensen LK. Effect of diphenylhydantoin on the metabolism of dicoumarol in man. Acta Medica Scandinavica 189: 15–19, 1971a

    Article  PubMed  CAS  Google Scholar 

  • Hansen JM, Siersbaek-Nielsen K, Skovsted L. Carbamazepine-induced acceleration of diphenylhydantoin and warfarin metabolism in man. Clinical Pharmacology and Therapeutics 12: 539–543, 1971b

    PubMed  CAS  Google Scholar 

  • Haque N, Thrasher K, Werk EE, Knowles HC, Sholiton U. Studies on dexamethasone metabolism in man: effect of diphenylhydantoin. Journal of Endocrinology and Metabolism 34: 44–50, 1972

    Article  CAS  Google Scholar 

  • Hatton RC. Dietary interaction with phenytoin. Clinical Pharmacy 3: 110–111, 1984

    PubMed  CAS  Google Scholar 

  • Heipertz R, Pilz H. Interaction of nitrofurantoin with diphenylhydantoin. Journal of Neurology 218: 297–301, 1978

    Article  PubMed  CAS  Google Scholar 

  • Hendeles L. Wyatt R, Weinberger M, Schottelius D. Fincham R. Decreased oral phenytoin absorption following concurrent theophylline administration. Journal of Allergy and Clinical Immunology 63: 156. 1979

    Google Scholar 

  • Hetzel DJ, Bochner F, Hallpike JF. Shearman DJC. Cimetidine interaction with phenytoin. British Medical Journal 282: 1512, 1981

    Article  PubMed  CAS  Google Scholar 

  • Hooks MA, Longe RL.Taylor AT, Francisco GE. Recovery of phenytoin from an enterai nutrient formula. American Journal of Hospital Pharmacy 43: 685–688, 1986

    PubMed  CAS  Google Scholar 

  • Houghton GW, Richens A. Inhibition of phenytoin metabolism by sulthiame in epileptic patients. Brush Journal of Clinical Pharmacology 1: 59–66, 1974a

    Article  CAS  Google Scholar 

  • Houghton GW, Richens A. Phenytoin intoxication induced by sulthiame in epileptic patients. Journal of Neurology. Neurosurgery, and Psychiatry 37: 275–281, 1974b

    Article  CAS  Google Scholar 

  • Hsieh YY, Huang JD, Lai ML, Lin MS, Liu RT, et al. The complexity of cimetidine-phenytoin interaction. Journal of the Formosan Medical Association 85: 395–402, 1986

    PubMed  CAS  Google Scholar 

  • Huang CY, McLeod JG, Sampson D, Hensley WJ. Clonazepam in the treatment of epilepsy. Medical Journal of Australia 2: 5–8, 1974

    PubMed  CAS  Google Scholar 

  • Iteogu MO, Murphy JE, Shleiffer N, Davis R. Effect of cimetidine on single-dose phenytoin kinetics. Clinical Pharmacy 2: 302–304, 1983

    PubMed  CAS  Google Scholar 

  • Jensen JC, Gugler R. Interaction between metronidazole and drugs eliminated by oxidative metabolism. Clinical Pharmacology and Therapeutics 37: 407–410, 1985

    Article  PubMed  CAS  Google Scholar 

  • Jensen ON, Olesen OV. Subnormal serum folate due to anticon-vulsant therapy. Archives of Neurology 22: 181–182, 1970

    Article  PubMed  CAS  Google Scholar 

  • Johannessen SI, Slrandjord RE. The influence of phenobarbitone and phenytoin on carbamazepine. In Schneider et al. (Eds) Clinical pharmacology of anti-epileptic drugs, pp. 201–205, Springer-Verlag, Berlin. 1975

    Chapter  Google Scholar 

  • Johannessen SI, Strandjord RE, Munthe-Kaas AW. Lack of effect of clonazepam on serum levels of diphenylhydantoin, phenobarbital and carbamazepine. Acta Neurologica Scandinavica 55: 506–512, 1977

    Article  PubMed  CAS  Google Scholar 

  • Jones DH, Bleehen NM, Workman P, Smith NC. The role of microsomal enzyme inducers in the reduction of misonidazole neurotoxicity. British Journal of Radiology 56: 865–870, 1983

    Article  PubMed  CAS  Google Scholar 

  • Jubiz W, Levinson RA, Meikle AW, West CD, Tyler FH. Absorption and conjugation of metyrapone during diphenylhydantoin therapy: mechanism of the abnormal response to oral metyrapone. Endocrinology 86: 328–331, 1970a

    Article  PubMed  CAS  Google Scholar 

  • Jubiz W, Meikle AW, Levinson RA, Mizutani S, West CD. Effect of diphenylhydantoin on the metabolism of dexamethasone. New England Journal of Medicine 283: 11–14, 1970b

    Article  PubMed  CAS  Google Scholar 

  • Jusko WJ, Schentag JJ, Clark JH, Gardener M, Yurchak AM. Enhanced biotransformation of theophylline in marihuana and tobacco smokers. Clinical Pharmacology and Therapeutics 24: 406–410, 1978

    CAS  Google Scholar 

  • Kapetanovic IM, Torchin CD, Kupferberg HJ, Treiman DM, Di Giorgio C, et al. Pharmacokinetic profile of flunarizine after single and multiple dosing in epileptic patients receiving co-medication. Epilepsia 29: 770–774, 1988

    Article  PubMed  CAS  Google Scholar 

  • Karch FE, Wardell WM. Effect of halofenate on the serum binding of phenytoin. British Journal of Clinical Pharmacology 4: 625–626, 1977

    Article  PubMed  CAS  Google Scholar 

  • Kater RMH, Roggin G, Tobon F, Zieve P, Iber FL. Increased rate of clearance of drugs from the circulation of alcoholics. American Journal of the Medical Sciences 258: 35–39, 1969

    Article  PubMed  CAS  Google Scholar 

  • Kay L, Kampmann JP, Svendsen TL, Vergman B, Hansen JEM, et al. Influence of rifampicin and isoniazid on the kinetics of phenytoin. British Journal of Clinical Pharmacology 20: 323–326, 1985

    Article  PubMed  CAS  Google Scholar 

  • Keith DA, Gallop PM. Phenytoin, hemorrhage, skeletal defects and vitamin K in the newborn. Medical Hypothesis 5: 1347–1351, 1979

    Article  CAS  Google Scholar 

  • Keith DA, Gundberg CM, Gallop PM. Phenytoin therapy and hemorrhagic disease. Journal of Pediatrics 97: 501, 1980

    PubMed  CAS  Google Scholar 

  • Keith DA, Gundberg CM, Japour A, Aranoff J, Alvarez N, et al. Vitamin K-dependenl proteins and anticonvulsant medication. Clinical Pharmacology and Therapeutics 34: 529–532, 1983

    Article  PubMed  CAS  Google Scholar 

  • Keller E, Sulzer U, Brennes M, Schollmeyer P, Hoppe-Seyler G. Disposition of hydrochlorothiazide during phenytoin treatment. Klinische Wochenschrift 59: 1223–1224, 1981

    Article  PubMed  CAS  Google Scholar 

  • Kenyon IE. Unplanned pregnancy in an epileptic. British Medical Journal 1: 686–687, 1972

    Article  PubMed  CAS  Google Scholar 

  • Keown PA, Laupacis A, Carruthers G, Stawecki M, Koegler J, et al. Interaction between phenytoin and cyclosporine following organ transplantation. Transplantation 38: 304–306, 1984

    PubMed  CAS  Google Scholar 

  • Keown PA, Stiller CR, Ulan RA, Sinclair NR, Wall WJ, et al. Immunological and pharmacological monitoring in the clinical use of Cyclosporin A. Lancet 1: 686–689, 1981

    Article  PubMed  CAS  Google Scholar 

  • Kessler JM, Keys PW, Stafford RW. Disopyramide and phenytoin interaction. Clinical Pharmacy 1: 263–264, 1982

    PubMed  CAS  Google Scholar 

  • Khoo K, Mendels J, Rothbart M, Garland WA, Colburn WA, et al. Influence of phenytoin and phenobarbital on the disposition of a single oral dose of clonazepam. Clinical Pharmacology and Therapeutics 28: 368–375, 1980

    Article  PubMed  CAS  Google Scholar 

  • Kilpatrick CJ, Wanwimolruk S, Wing LMH. Plasma concentrations of unbound phenytoin in the management of epilepsy. British Journal of Clinical Pharmacology 17: 539–546, 1984

    Article  PubMed  CAS  Google Scholar 

  • Kiorboe E. Phenytoin intoxication during treatment with Anta-buse® (disulfiram). Epilepsia 7: 246–249, 1966

    Article  PubMed  CAS  Google Scholar 

  • Koch KM, Ludwick BT, Levy RH. Phenytoin-valproic acid interaction in rhesus monkey. Epilepsia 22: 19–25, 1981

    Article  PubMed  CAS  Google Scholar 

  • Koch-Weser J. Hemorrhagic reactions and drug interactions in 500 warfarin-treated patients. Clinical Pharmacology and Therapeutics 14: 139, 1973

    Google Scholar 

  • Koup JR, Gibaldi M, McNamara P, Hilligoss DM, Colburn WA, et al. Interaction of chloramphemcol with phenytoin and phenobarbital. Clinical Pharmacology and Therapeutics 24: 571–575, 1978

    PubMed  CAS  Google Scholar 

  • Krasinski K, Kusmiesz H, Nelson JD. Pharmacologic interactions among chloramphenicol, phenytoin and phenobarbital. Pediatrie Infectious Disease 1: 232–235, 1982

    Article  CAS  Google Scholar 

  • Kristensen M. Hansen JM. Skovsted L. The influence of phenobarbital on the half-life of diphenylhydantoin in man. Acta Medica Scandinavica 185: 347–350, 1969

    Article  PubMed  CAS  Google Scholar 

  • Krueger KA, Garnett WR, Comstock TJ, Fitzsimmons WE, Karnes HT, et al. Effect of two administration schedules of an enterai nutrient formula on phenytoin bioavailability. Epilepsia 28: 706–712, 1987

    Article  PubMed  CAS  Google Scholar 

  • Kulshrestha VK, Thomas M, Wadsworth J, Richens A. Interaction between phenytoin and antacids. British Journal of Clinical Pharmacology 6: 177–179, 1978

    Article  PubMed  CAS  Google Scholar 

  • Kutt H. Biochemical and genetic factors regulating dilantin metabolism in man. Annals of the New York Academy of Sciences 179: 704–722, 1971

    Article  CAS  Google Scholar 

  • Kutt H. Interactions of antiepileptic drugs. Epilepsia 16: 393–402, 1975

    Article  PubMed  CAS  Google Scholar 

  • Kutt H, Brennan R, Dehejia H, Verebely K. Diphenylhydanloin intoxication — a complication of isoniazid therapy. American Review of Respiratory Disease 101: 377–384, 1970

    PubMed  CAS  Google Scholar 

  • Kutt H, Haynes J, Verebely K, McDowell F. The effect of phenobarbital on plasma diphenylhydanloin level and metabolism in man and in rat liver microsomes. Neurology 19: 611–616, 1969

    Article  PubMed  CAS  Google Scholar 

  • Kutt H, Winters W, McDowell FH. Depression of parahydrox-ylation of diphenylhydantoin by antituberculosis chemotherapy. Neurology 16: 594–602, 1966

    Article  PubMed  CAS  Google Scholar 

  • Kutt H, Wölk M, Scherman R, McDowell F. Insufficient para-hydroxylation as a cause of diphenylhydantoin toxicity. Neurology 14: 542–548, 1964

    Article  PubMed  CAS  Google Scholar 

  • Lambie DG, Johnson RH. The effects of phenytoin on phenobarbitone and primidone metabolism. Journal of Neurology. Neurosurgery, and Psychiatry 44: 148–151, 1981

    Article  CAS  Google Scholar 

  • Lambie DG, Johnson RH, Nanda RN, Shakir RA. Therapeutic and pharmacokinelic effects of increasing phenytoin in chronic epileptics on multiple drug therapy. Lancet 2: 386–389, 1976

    Article  PubMed  CAS  Google Scholar 

  • Larsen PR, Atkinson AJ, Wellman HN, Goldsmith RE. The effect of diphenylhydantoin on thyroxine metabolism in man. Journal of Clinical Investigation 49: 1266–1279, 1970

    Article  PubMed  CAS  Google Scholar 

  • Lawson LA, Blouin RA, Smith RB, Rapp RP, Young AB. Phenytoin-dexamethasone interaction: a previously unreported observation. Surgical Neurology 16: 23–25, 1980

    Article  Google Scholar 

  • Leonard RF, Knott PJ, Rankin GO, Robinson DS. Melnick DE Phenytoin-salicyclate interaction. Clinical Pharmacology and Therapeutics 29: 56–60, 1981

    Article  PubMed  CAS  Google Scholar 

  • Levine M, Jones MW, Sheppard I. Differential effect of cimetidine on serum concentrations of carbamazepine and phenytoin. Neurology 35: 562–565, 1985

    Article  PubMed  CAS  Google Scholar 

  • Levine M, Sheppard I. Biphasic interaction of phenytoin with warfarin. Clinical Pharmacy 3: 200–203, 1984

    PubMed  CAS  Google Scholar 

  • Loiseau P, Bossi L, Guyot M, Orofiamma B. Morselli PL Double-blind crossover trial of progabide versus placebo in severe epilepsies. Epilepsia 24: 703–715, 1983

    Article  PubMed  CAS  Google Scholar 

  • Lowy MT, Meltzer HY. Dexamethasone bioavailability: implications for DST research. Biological Psychiatry 22: 373–385, 1987

    Article  PubMed  CAS  Google Scholar 

  • Lumholtz B, Siersbaek-Nielsen K, Skovsted L, Kampmann J, Hansen JM. Sulfamethizole-induced inhibition of diphenylhydantoin, tolbutamide, and warfarin metabolism. Clinical Pharmacology and Therapeutics 17: 731–734, 1975

    PubMed  CAS  Google Scholar 

  • Lunde PKM, Rane A, Yaffe SJ, Lund L, Sjoqvist F. Plasma protein binding of diphenylhydantoin in man: interaction with other drugs and the effect of temperature and plasma dilution. Clinical Pharmacology and Therapeutics 11: 846–855, 1970

    PubMed  CAS  Google Scholar 

  • MacCosbe PE, Toomey K. Interaction of phenytoin and folic acid. Clinical Pharmacy 2: 362–369, 1983

    PubMed  CAS  Google Scholar 

  • McElnay JC, Uprichard G, Collier PS. The effect of activated dimethicone and a proprietary antacid preparation containing this agent on the absorption of phenytoin. British Journal of Clinical Pharmacology 13: 501–505, 1982

    Article  PubMed  CAS  Google Scholar 

  • McGovern B, Geer VR, LaRaia PJ, Garan H, Ruskin JN. Possible interaction between amiodarone and phenytoin. Annals of Internal Medicine 101: 650–651, 1984.

    PubMed  CAS  Google Scholar 

  • McLelland J, Jack W. Phenytom/dexamethasone interaction: a clinical problem. Lancet 1: 1096–1097, 1978

    Article  PubMed  CAS  Google Scholar 

  • Makki KA, Perucca E, Richens A. Metabolic effects of folic acid replacement therapy in folate-deficient epileptic patients. In Johannessen et al. (Eds) Antiepileptic therapy: advances in drug monitoring, pp. 391–396, Raven Press, New York, 1980

    Google Scholar 

  • Marquis JF, Carruthers SG, Spence JD, Brownstone YS, Toogood JH. Phenytoin-theophylline interaction. New England Journal of Medicine 307: 1189–1190, 1982

    Article  PubMed  CAS  Google Scholar 

  • Matos JA. Fisher JD, Kim SG. Disopyramide-phenytoin interaction. Clinical Research 29: 655A. 1981

    Google Scholar 

  • Mattson RH, Gallagher BB, Reynolds EH, Glass D. Folate therapy in epilepsy: a controlled study. Archives of Neurology 29: 78–81, 1973

    Article  PubMed  CAS  Google Scholar 

  • Maurer G, Loosli HR, Schreier E, Keller B. Disposition of cyclosporine in several animal species and man: structural elucidation of its metabolites. Drug Metabolism and Disposition 12: 120–126, 1984

    PubMed  CAS  Google Scholar 

  • Mauro LS, Mauro VF, Brown DL, Somani P. Enchancement of phenytoin elimination by multiple-dose activated charcoal. Annals of Emergency Medicine 16: 1132–1135, 1987

    Article  PubMed  CAS  Google Scholar 

  • May T, Rambeck B. Serum concentrations of valproic acid: influence of dose and comedication. Therapeutic Drug Monitoring 7: 387–390, 1985

    Article  PubMed  CAS  Google Scholar 

  • Maynard GA. Jones KM, Guidry JR. Phenytoin absorption from tube feedings. Archives of Internal Medicine 147: 1821, 1987

    Article  PubMed  CAS  Google Scholar 

  • Meikle AW, Jubiz W, Matsukura S, West CD, Tyler FH. Effect of diphenylhydantoin on the metabolism of metyrapone and release of ACTH in man. Journal of Clinical Endocrinology and Metabolism 29: 1553–1558, 1969

    Article  PubMed  CAS  Google Scholar 

  • Mihaly GW, Vajda FJ, Miles JL, Louis WJ. Single and chronic dose pharmacokinetic studies of sodium valproate in epileptic patients. European Journal of Clinical Pharmacology 16: 23–29, 1979

    Article  PubMed  CAS  Google Scholar 

  • Miller M, Cosgriff J, Kwong T, Morken DA. Influence of phenytoin on theophylline clearance. Clinical Pharmacology and Therapeutics 35: 666–669, 1984

    Article  PubMed  CAS  Google Scholar 

  • Miller RR, Porter J, Greenblatt DJ. Clinical importance of the interaction of phenytoin and isoniazid. Chest 75: 356–358, 1979

    Article  PubMed  CAS  Google Scholar 

  • Milne RW, Coulthard K, Nation RL, Penna AC, Roberts G, et al. Lack of effect of erythromycin on the pharmacokinetics of single oral doses of phenytoin. British Journal of Clinical Pharmacology 26: 330–333, 1988

    Article  PubMed  CAS  Google Scholar 

  • Mitchell AS. Holland JT. Fluconazole and phenytoin: a predictable interaction. British Medical Journal 298: 1315. 1989

    Article  PubMed  CAS  Google Scholar 

  • Mofenson HC, Caraccio TR, Greensher J, D’Agostino R, Rossi A. Gastrointestinal dialysis with activated charcoal and cathartic in the treatment of adolescent intoxications. Clinical Pediatrics 24: 678–684, 1985

    Article  PubMed  CAS  Google Scholar 

  • Monks A, Boobis S, Wadsworth J, Richens A. Plasma protein binding interaction between phenytoin and valproic acid in vitro. British Journal of Clinical Pharmacology 6: 487–492, 1978

    Article  PubMed  CAS  Google Scholar 

  • Monks A, Richens A. Effect of single doses of sodium valproate on serum phenytoin levels and protein binding in epileptic patients. Clinical Pharmacology and Therapeutics 27: 89–95, 1980

    Article  PubMed  CAS  Google Scholar 

  • Moody JP, Whyte SF, MacDonald AJ, Naylor GJ. Pharmacokinetic aspects of protriptyline plasma levels. European Journal of Clinical Pharmacology 11: 51–56, 1977

    Article  PubMed  CAS  Google Scholar 

  • Moore JL, Paterson ICM, Dawes PJDK, Henk JM. Misonidazole in patients receiving radical radiotherapy: pharmacokinetic effects of phenytoin tumor response and neurotoxicity. International Journal of Radiation, Oncology, Biology, Physics 8: 361–364, 1982

    Article  CAS  Google Scholar 

  • Moore JL, Paterson ICM, Newman H, Venables S. Phenytoin-induced changes in the pharmacokinetics of misonidazole in radiotherapy patients. British Journal of Cancer 44: 592–596, 1981

    Article  PubMed  CAS  Google Scholar 

  • Morselli PL, Rizzo M, Garattini S. Interaction between phenobarbital and diphenylhydantoin in animals and in epileptic patients. Annals of the New York Academy of Sciences 179: 88–107, 1971

    Article  PubMed  CAS  Google Scholar 

  • Murray FJ. Outbreak of unexpected reactions among epileptics taking isoniazid. American Review of Respiratory Diseases 86: 729–732, 1962

    CAS  Google Scholar 

  • Nanda RN, Johnson RH, Keogh HJ, Lambic DG, Melville ID. Treatment of epilepsy with clonazepam and its effect on other anticonvulsants. Journal of Neurology, Neurosurgery, and Psychiatry 40: 538–543, 1977

    Article  PubMed  CAS  Google Scholar 

  • Nappi JM. Warfarin and phenytoin interaction. Annals of Internal Medicine 90: 852. 1979

    PubMed  CAS  Google Scholar 

  • Nawishi S, Hathway N, Turner P. Interactions of anticonvulsant drugs with mianserin and nomifensine. Lancet 2: 871–872, 1981

    Article  Google Scholar 

  • Neef C, de Voogd-van der Straaten I. An interaction between cytostatic and anticonvulsant drugs. Clinical Pharmacology and Therapeutics 43: 372–375, 1988

    Article  PubMed  CAS  Google Scholar 

  • Neuvonen PJ, Elfving SM, Elonen E. Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man. European Journal of Clinical Pharmacology 13: 213–218, 1978

    Article  PubMed  CAS  Google Scholar 

  • Neuvonen PJ, Lehtovaara R, Bardy A, Elomaa E. Antipyretic analgesics in patients on antiepileptic drug therapy. European Journal of Clinical Pharmacology 15: 263–268, 1979

    Article  PubMed  CAS  Google Scholar 

  • Neuvonen PJ, Tokola RA, Kaste M. Cimetidine-phenytoin interaction: effect on serum phenytoin concentration and antipyr-ine test. European Journal of Clinical Pharmacology 21: 215–220, 1981

    Article  PubMed  CAS  Google Scholar 

  • Nightingale J, Nappi JM. Effect of phenytoin on serum disopyramide concentrations. Clinical Pharmacy 6: 46–50, 1987

    PubMed  CAS  Google Scholar 

  • Nishimura LY, Armstrong EP, Plezia PM, Iacono RP. Influence of enterai feedings on phenytoin sodium absorption from capsules. Drug Intelligence and Clinical Pharmacy 22: 130–133, 1988

    PubMed  CAS  Google Scholar 

  • Notelovitz M, Tjapkes J, Ware M. Interaction between estrogen and dilantin in a menopausal woman. New England Journal of Medicine 304: 788–789, 1981

    Article  PubMed  CAS  Google Scholar 

  • O’Brien LS, Orme ML’E, Breckenridge AM. Failure of antacids to alter the pharmacokinetics of phenytoin. British Journal of Clinical Pharmacology 6: 176–177, 1978

    Article  PubMed  Google Scholar 

  • Odlind V, Johansson EDB. Free norethisterone as reflected by saliva concentrations of norethisterone during oral contraceptive use. Acta Endocrinologies 98: 470–476, 1981

    CAS  Google Scholar 

  • Odlind V, Olsson S-E. Enhanced metabolism of levonorgestrel during phenytoin treatment in a woman with Norplant® implants. Contraception 33: 257–261, 1986

    Article  PubMed  CAS  Google Scholar 

  • Olesen OV. Disulfiram (Antabuse®) as an inhibitor of phenytoin metabolism. Acta Pharmacologica et Toxicologica 24: 317–322, 1966

    Article  PubMed  CAS  Google Scholar 

  • Olesen OV. The influence of disulfiram and calcium carbimide on the serum diphenylhydantoin: excretion of HPPH in the urine. Archives of Neurology 16: 642–644, 1967

    Article  PubMed  CAS  Google Scholar 

  • Olesen OV, Jensen ON. Drug-interaction between sulthiame (Ospolot®) and phenytoin in the treatment of epilepsy. Danish Medical Bulletin 16: 154–158, 1969

    PubMed  CAS  Google Scholar 

  • Olesen OV, Jensen ON. The influence of folic acid on phenytoin (DPH) metabolism and the 24-hours fluctuation in urinary output of 5-(p-hydroxyphenyl)-5 phenyl-hydantoin (HPPH). Acta Pharmacologica et Toxicologica 28: 265–269, 1970

    Article  PubMed  CAS  Google Scholar 

  • Oppenheimer JH, Tavernetti RR. Studies on the thyroxine-diphenylhydantoin interaction: effect of 5,5′-diphenylhydantoin on the displacement of L-thyroxine from thyroxine-binding globulin (TBG). Endocrinology 71: 496–504, 1962

    Article  PubMed  CAS  Google Scholar 

  • Ozuna J, Friel P. Effect of enterai tube feeding on serum phenytoin levels. Journal of Neurosurgical Nursing 16: 289–291, 1984

    Article  PubMed  CAS  Google Scholar 

  • Patsalos PN, Lascelles PT. Valproate may lower serum-phenytoin. Lancet 1: 50–51, 1977

    Article  PubMed  CAS  Google Scholar 

  • Paxton JW. Effects of aspirin on salivary and serum phenytoin kinetics in healthy subjects. Clinical Pharmacology and Therapeutics 27: 170–178, 1980

    Article  PubMed  CAS  Google Scholar 

  • Pearce GA. Apparent inhibition of phenytoin absorption by an enterai nutrient formula. Australian Journal of Hospital Pharmacy 18: 289–292, 1988

    Google Scholar 

  • Penttila O, Neuvonen PJ, Aho K, Lehtovaara R. Interaction between doxycycline and some antiepileptic drugs. British Medical Journal 2: 470–472, 1974

    Article  PubMed  CAS  Google Scholar 

  • Perrild H, Hansen JM, Skovsted L, Simonsen K, Hegedus L, et al. Lack of stimulation of antipyrine and phenytoin metabolism by lithium carbonate in man. Acta Pharmacologica et Toxicologica 52: 315–317, 1983

    Article  PubMed  CAS  Google Scholar 

  • Perucca E. Free level monitoring of antiepileptic drugs: clinical usefulness and case studies. Clinical Pharmacokinetics 9(Suppl. 1): 71–78, 1984

    Article  PubMed  Google Scholar 

  • Perucca E, Garratt A, Hebdige S, Richens A. Water intoxication in epileptic patients receiving carbamazepine. Journal of Neurology, Neurosurgery, and Psychiatry 41: 713–718, 1978a

    Article  PubMed  CAS  Google Scholar 

  • Perucca E, Gatti G, Frigo GM, Crema A, Calzetti S, et al. Disposition of sodium valproate in epileptic patients. British Journal of Clinical Pharmacology 5: 495–499, 1978b

    Article  PubMed  CAS  Google Scholar 

  • Perucca E, Hebdige S, Frigo GM, Gatti G, Lecchini S, et al. Interaction between phenytoin and valproic acid: plasma protein and metabolic effects. Clinical Pharmacology and Therapeutics 28: 779–789, 1980

    Article  PubMed  CAS  Google Scholar 

  • Perucca E, Hedges A, Makki K, Hebdige S, Wadsworth J, et al. The comparative enzyme-inducing properties of antiepileptic drugs. British Journal of Clinical Pharmacology 7: 4I4P–4I5P. 1979

    Article  Google Scholar 

  • Perucca E, Hedges A, Makki KA, Ruprah M, Wilson JF, et al. A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients. British Journal of Clinical Pharmacology 18: 401–410, 1984

    Article  PubMed  CAS  Google Scholar 

  • Perucca E, Richens A. Interaction between phenyloin and imipramine. British Journal of Clinical Pharmacology 4: 485–486, 1977

    Article  PubMed  CAS  Google Scholar 

  • Perucca E, Richens A. Paracetamol disposition in normal subjects and in patients treated with antiepileptic drugs. British Journal of Clinical Pharmacology 7: 201–206, 1979a

    Article  PubMed  CAS  Google Scholar 

  • Perucca E, Richens A. Reduction of oral bioavailability of lignocainc by induction of first pass metabolism in epileptic patients. British Journal of Clinical Pharmacology 8: 21–31, 1979b

    Article  PubMed  CAS  Google Scholar 

  • Perucca E, Richens A. Reversal by phenytoin of carbamazepine-induced water intoxication: a pharmacokinetic interaction. Journal of Neurology, Neurosurgery, and Psychiatry 43: 540–545, 1980

    Article  PubMed  CAS  Google Scholar 

  • Petereit LB, Meikle AW. Effectiveness of prednisolone during phenytoin therapy. Clinical Pharmacology and Therapeutics 22: 912–916, 1977

    PubMed  CAS  Google Scholar 

  • Petruch F, Schuppel RVA, Steinhilber G. Effect of diphenylhydantoin on hepatic drug hydroxylation. European Journal of Clinical Pharmacology 7: 281–285, 1974

    Article  PubMed  CAS  Google Scholar 

  • Phillips P, Hansky J. Phenytoin toxicity secondary to cimetidine administration. Medical Journal of Australia 141: 602, 1984

    PubMed  CAS  Google Scholar 

  • Piafsky KM. Disease-induced changes in the plasma binding of basic drugs. Clinical Pharmacokinetics 5: 246–262, 1980

    Article  PubMed  CAS  Google Scholar 

  • Picard EH. Side effects of metronidazole. Mayo Clinic Proceedings 5: 401. 1983

    Google Scholar 

  • Pirttiaho HI, Sotaniemi EA, Ahokas JT, Pitkanen U. Liver size and indices of drug metabolism in epileptics. British Journal of Clinical Pharmacology 6: 273–278, 1978

    Article  PubMed  CAS  Google Scholar 

  • Pirttiaho HI, Sotaniemi EA, Pelkonen RO, Pitkanen U. Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants. European Journal of Clinical Pharmacology 22: 441–445, 1982

    Article  PubMed  CAS  Google Scholar 

  • Pond SM, Kretschzmar KM. Effect of phenytoin on meperidine clearance and normeperidine formation. Clinical Pharmacology and Therapeutics 30: 680–686, 1981

    Article  PubMed  CAS  Google Scholar 

  • Porro MG, Kupferberg HJ, Porter RJ, Theodore WH, Newmark ME. Phenytoin: an inhibitor and inducer of primidone metabolism in an epileptic patient. British Journal of Clinical Pharmacology 14: 294–297, 1982

    Article  PubMed  CAS  Google Scholar 

  • Prescott LF. Critchley JAJH. Balali-Mood M. Pentland B. Effects of microsomal enzyme induction on paracetomol metabolism in man. British Journal of Clinical Pharmacology 12: 149–153 1981

    PubMed  CAS  Google Scholar 

  • Prichard PJ, Walt RP, Kitchingman GK, Somerville KW, Langman MJS, et ai. Oral phenytoin pharmacokinetics during omeprazole therapy. British Journal of Clinical Pharmacology 24: 543–545, 1987

    Article  PubMed  CAS  Google Scholar 

  • Rambeck B. Pharmacological interactions of mesuximide with phenobarbital and phenytoin in hospitalized epileptic patients. Epilepsia 20: 147–156, 1979

    Article  PubMed  CAS  Google Scholar 

  • Rameis H. On the interaction between phenytoin and digoxin. European Journal of Clinical Pharmacology 29: 49–53, 1985

    Article  PubMed  CAS  Google Scholar 

  • Rating D, Jager-Roman E, Nau H, Kuhnz W, Helge H. Enzyme induction in neonates after fetal exposure to antiepileptic drugs. Pediatric Pharmacology 3: 209–218, 1983

    PubMed  CAS  Google Scholar 

  • Reed RC, Schwartz HJ. Phenytoin-theophylline-quinidine interaction. New England Journal of Medicine 308: 724–725, 1983

    Article  Google Scholar 

  • Reynolds EH, Fenton G, Fenwick P, Johnson AL, Laundy M. Interaction of phenytoin and primidone. British Medical journal 2: 594–595, 1975

    Article  PubMed  CAS  Google Scholar 

  • Richens A, Houghton GW. Effect of drug therapy on the metabolism of phenytoin. In Schneider et al. (Eds) Clinical Pharmacology of Antiepileptic Drugs, pp. 87–95, Springer-Verlag, Berlin. 1975

    Chapter  Google Scholar 

  • Riddell JG. Salem SAM. McDevitt DG. Interaction between phenytoin and dichloralphenazone. British Journal of Clinical Pharmacology 9: 118P. 1980

    Article  Google Scholar 

  • Rivey MP, Schottelius DD, Berg MJ. Phenytoin-folic acid: a review. Drug Intelligence and Clinical Pharmacy 18: 292–301, 1984

    PubMed  CAS  Google Scholar 

  • Roberts CJC, Daneshmend TK, Macfarlane D, Dieppe PA. Anli-convulsant intoxication precipitated by azapropazone. Postgraduate Medical Journal 57: 191–192, 1981

    Article  PubMed  CAS  Google Scholar 

  • Roe TF, Podosin RL, Blaskovics ME. Drug interaction: diazoxide and diphenylhydantoin. Journal of Pediatrics 87: 480–484, 1975

    Article  PubMed  CAS  Google Scholar 

  • Rolan PE. Somogyi AA. Drew MJR, Cobain WG, South D. et al. Phenytoin intoxication during treatment with parenteral miconazole. British Medical Journal 287: 1760. 1983

    Article  PubMed  CAS  Google Scholar 

  • Roots I, Holbe R, Hovermann W, Nigam S, Heinemeyer G, et al. Quantitative determination by HPLC of urinary 6β-hydroxycortisol, an indicator of enzyme induction by rifampicin and antiepileptic drugs. European Journal of Clinical Pharmacology 16: 63–71, 1979

    Article  PubMed  CAS  Google Scholar 

  • Rose JQ, Choi HK, Schentag JJ, Kinkel WR, Jusko WJ. Intoxication caused by interaction of chloramphenicol and phenytoin. Journal of the American Medical Association 237: 2630–2631, 1977

    Article  PubMed  CAS  Google Scholar 

  • Routledge PA, Stargel WW, Finn AL, Barchowsky A. Shand DG Lignocaine disposition in blood in epilepsy. British Journal of Clinical Pharmacology 12: 663–666, 1981

    Article  PubMed  CAS  Google Scholar 

  • Rowland M, Gupta SK. Cyclosporin-phenytoin interaction: reevaluation using metabolite data. British Journal of Clinical Pharmacology 24: 329–334, 1987

    Article  PubMed  CAS  Google Scholar 

  • Saavedra IN, Aguilera LI, Faure E, Galdames DG. Phenytoin/clonazepam interaction. Therapeutic Drug Monitoring 7: 481–484, 1985

    Article  PubMed  CAS  Google Scholar 

  • Sackellares JC, Sato S, Dreifuss FE. Penry JK Reduction of steady-state valproate levels by other antiepileptic drugs. Epilepsia 22: 437–441, 1981

    Article  PubMed  CAS  Google Scholar 

  • Salem RB, Breland BD, Mishra SK, Jordan JE. Effect of cimelidine on phenyloin serum levels. Epilepsia 24: 284–288, 1983

    Article  PubMed  CAS  Google Scholar 

  • Sambol NC, Upton RA, Chremos AN, Lin ET, Williams RL. A comparison of the influence of famolidine and cimetidine on phenytoin elimination and hepatic blood flow. British Journal of Clinical Pharmacology 27: 83–87, 1989

    Article  PubMed  CAS  Google Scholar 

  • Sandor P, Sellers EM, Dumbrell M, Khouw V. Effect of short-and long-term alcohol use on phenytoin kinetics in chronic alcoholics. Clinical Pharmacology and Therapeutics 30: 390–397, 1981

    Article  PubMed  CAS  Google Scholar 

  • Sands CD, Robinson JD, Salem RB, Stewart RB, Muniz C. Effect of thiondazine on phenytoin serum concentration: a retrospective study. Drug Intelligence and Clinical Pharmacy 21: 267–272, 1987

    PubMed  CAS  Google Scholar 

  • Sandyk R. Phenytoin toxicity induced by interaction with ibuprofen. South African Medical Journal 62: 592, 1982

    PubMed  CAS  Google Scholar 

  • Sansom LN. Beran RC. Schapel GJ. Interaction between phenytoin and valproate. Medical Journal of Australia 2: 212. 1980

    PubMed  CAS  Google Scholar 

  • Saunders MI, Dische S. Anderson P, Flockhart IR. The neurotoxicity of misonidazole and its relationship to dose, half-life and concentration in the serum British Journal of Cancer 37(Suppl. 3): 268–270, 1978

    Google Scholar 

  • Sawchuk RJ, Rector TS, Fordice JJ, Leppik IE. Effect of influenza vaccination on plasma phenytoin concentrations. Therapeutic Drug Monitoring 1: 285–288, 1979

    Article  PubMed  CAS  Google Scholar 

  • Schmidt D. The effect of phenytoin and ethosuximide on primidone metabolism in patients with epilepsy. Journal of Neurology 209: 115–123, 1975

    Article  PubMed  CAS  Google Scholar 

  • Schmidt D, Utech K. Progabide for refractory partial epilepsy: a controlled add-on trial. Neurology 36: 217–221, 1986

    Article  PubMed  CAS  Google Scholar 

  • Schulz P, Giacomini K.M, Luttrell S, Tumer-Tamiyasu K, Blaschke TF. Effect of low doses of heparin on the plasma binding of phenytoin and prazosin in normal man. European Journal of Clinical Pharmacology 25: 211–214, 1983

    Article  PubMed  CAS  Google Scholar 

  • Scott AK, Khir ASM, Steele WH, Hawksworth GM, Petrie JC. Oxazepam pharmacokinetics in patients with epilepsy treated long-term with phenytoin alone or in combination with pheno-barbitone. British Journal of Clinical Pharmacology 16: 441–444, 1983

    Article  PubMed  CAS  Google Scholar 

  • Shackleford EJ. Watson FT. Amiodarone-phenytoin interaction. Drug Intelligence and Clinical Pharmacy 21: 921. 1987

    PubMed  CAS  Google Scholar 

  • Shaw PN, Houston JB, Rowland M, Hopkins K, Thiercelin JF, et al. Antipyrine metabolite kinetics in healthy human volunteers during multiple dosing of phenytoin and carbamazepine. British Journal of Clinical Pharmacology 20: 611–618, 1985

    Article  PubMed  CAS  Google Scholar 

  • Shenfield GM. Drug interactions with oral contraceptive preparations. Medical Journal of Australia 144: 205–211, 1986

    PubMed  CAS  Google Scholar 

  • Sjo O, Hvidberg EF, Naestoft J, Lund M. Pharmacokinetics and side-effects of clonazepam and its 7-amino-metabolite in man. European Journal of Clinical Pharmacology 8: 249–254, 1975

    Article  PubMed  CAS  Google Scholar 

  • Sklar SJ, Wagner JC. Enhanced theophylline clearance secondary to phenytoin therapy. Drug Intelligence and Clinical Pharmacy 19: 34–36, 1985

    PubMed  CAS  Google Scholar 

  • Skovsted L, Kristensen M, Hansen JM, Siersbaek-Nielsen K. The effect of different oral anticoagulants on diphenylhydantoin (DPH) and tolbutamide metabolism. Acta Medica Scandinav-ica 199: 513–515, 1976

    Article  CAS  Google Scholar 

  • Smart HL, Somerville KW, Williams J, Richens A, Langman MJS. The effects of sucralfate upon phenytoin absorption in man. British Journal of Clinical Pharmacology 20: 238–240, 1985

    Article  PubMed  CAS  Google Scholar 

  • Solomon HM, Reich S, Spirt N, Abrams WB. Interactions between digitoxin and other drugs in vitro and in vivo. Annals of the New York Academy of Sciences 179: 362–368, 1971

    Article  PubMed  CAS  Google Scholar 

  • Solomon HM, Schrogie JJ. The effect of phenyramidol on the metabolism of diphenylhydantoin Clinical Pharmacology and Therapeutics 8: 554–556, 1967

    CAS  Google Scholar 

  • Sordillo P, Sagransky DM, Mercado R, Michelis MF. Carbam-azepine-induced syndrome of inappropriate antidiuretic hormone secretion. Archives of Internal Medicine 138: 299–301, 1978

    Article  PubMed  CAS  Google Scholar 

  • Sotaniemi EA, Pelkonen RO, Ahokas J, Pirttiaho HI, Ahlqvist J. Drug metabolism in epileptics: in vivo and in vitro correlations. British Journal of Clinical Pharmacology 5: 71–76, 1978

    Article  PubMed  CAS  Google Scholar 

  • Stjernholm MR, Katz FH. Effects of diphenylhydantoin, phenobarbital, and diazepam on the metabolism of methylprednisolone and its sodium succinate. Journal of Clinical Endocrinology and Metabolism 41: 887–893, 1975

    Article  PubMed  CAS  Google Scholar 

  • Surks MI, Ordene KW, Mann DN, Kumara-Sin MH. Diphenylhydantoin inhibits the thyrotropin response to thyrotropin-re-leasing hormone in man and rat. Journal of Clinical Endocrinology and Metabolism 56: 940–945, 1983

    Article  PubMed  CAS  Google Scholar 

  • Svendsen TL, Kristensen MB, Hansen JM, Skovsted L. The influence of disulfiram on the half life and metabolic clearance rate of diphenylhydantoin and tolbutamide in man. European Journal of Clinical Pharmacology 9: 439–441, 1976

    Article  CAS  Google Scholar 

  • Sylvester RK, Lewis FB, Caldwell KC, Lobell M, Perri R, et al. Impaired phenytoin bioavailabihty secondary to cisplatinum, vinblastine, and bleomycin. Therapeutic Drug Monitoring 6: 302–305, 1984

    Article  PubMed  CAS  Google Scholar 

  • Tanay A, Yust I, Peresecenschi G, Abramov AL, Aviram A. Long-term treatment of the syndrome of inappropriate antidiuretic hormone secretion with phenytoin. Annals of Internal Medicine 90: 50–52, 1979

    PubMed  CAS  Google Scholar 

  • Taylor JW, Alexander B, Lyon LW. Mathematical analysis of a phenytoin-disulfiram interaction. American Journal of Hospital Pharmacy 38: 93–95, 1981

    PubMed  CAS  Google Scholar 

  • Tiula E. Neuvonen PJ. Antiepileptic drugs and alpha1-acid glycoprotein. New England Journal of Medicine 307: 1148. 1982

    PubMed  CAS  Google Scholar 

  • Tjellesen L, Christiansen C. Serum vitamin D metabolites in epileptic patients treated with 2 different anti-convulsants. Acta Neurologica Scandinavica 66: 335–341, 1982

    Article  PubMed  CAS  Google Scholar 

  • Tomson T, Spina E, Wedlund J-E. Minor additive inducing effects of phenobarbital on carbamazepine clearance in patients on combined carbamazepine-phenyloin therapy. Therapeutic Drug Monitoring 9: 117–119, 1987

    Article  PubMed  CAS  Google Scholar 

  • Tong TG, Pond SM, Kreek MJ, Jaffery NF, Benowitz NL. Phenytoin-induced methadone withdrawal. Annals of Internal Medicine 94: 349–351, 1981

    PubMed  CAS  Google Scholar 

  • Traskman L, Asberg M, Bertilsson L, Cronholm B, Meilstrom B, el al. Plasma levels of chlorimipramine and its demethyl metabolite during treatment of depression. Clinical Pharmacology and Therapeutics 26: 600–610, 1979

    PubMed  CAS  Google Scholar 

  • Treiman DM, Ben-Menachem E. Inhibition of carbamazepine and phenytoin metabolism by nafimidone, a new antiepileptic drug. Epilepsia 28: 699–705, 1987

    Article  PubMed  CAS  Google Scholar 

  • Tsuei SE, Moore RG, Ashley JJ, McBride WG, Disposition of synthetic glucocorticoids I. Pharmacokinetics of dexametha-sone in healthy adults. Journal of Pharmacokinetics and Bio-pharmaceutics 7: 249–264, 1979

    Article  CAS  Google Scholar 

  • Urbano AM. Phenytoin-quinidine interaction in a patient with recurrent ventricular tachyarrhythmias. New England Journal of Medicine 308: 225. 1983

    PubMed  CAS  Google Scholar 

  • Vajda FJE. Prineas RJ. Lovell RRH. Interaction between phenytoin and the benzodiazepines. British Medical Journal 1: 346, 1971

    Article  PubMed  CAS  Google Scholar 

  • Victor A, Lundeburg PO, Johansson EDB. Induction of sex hormone binding globulin by phenytoin. British Medical Journal 2: 934–935, 1977

    Article  PubMed  CAS  Google Scholar 

  • Viukari NMA. Folic acid and anticonvulsants. Lancet 1: 980. 1968

    PubMed  CAS  Google Scholar 

  • Walker MD, Strike TA. Misonidazole peripheral neuropathy: its relationship to plasma concentration and other drugs. Cancer Clinical Trials 3: 105–109, 1980

    PubMed  CAS  Google Scholar 

  • Wasserman TH, Phillips TL, Van Raalle G. The neurotoxicity of misonidazole: potential modifying role of phenytoin sodium and dexamethasone. British Journal of Radiology 53: 172–173, 1980

    Article  PubMed  CAS  Google Scholar 

  • Watts RW, Hetzel DJ, Bochner F, Hallpike JF, Hann CS, et al. Lack of interaction between ranitidine and phenytoin. British Journal of Clinical Pharmacology 15: 499–500, 1983

    Article  PubMed  CAS  Google Scholar 

  • Weber M, Verspignani H. Remy MC, Regnier F. Bossi L. Controlled trial of progabide versus placebo in severe therapy-resistant epilepsies. In Bartholini et al. (Eds) Epilepsy and gaba receptor agonists: basic and therapeutic research, pp. 353–361, Raven Press, New York. 1985

    Google Scholar 

  • Weichbrodt GD, Elliot DP. Treatment of phenytoin toxicity with repeated doses of activated charcoal. Annals of Emergency Medicine 16: 1387–1389, 1987

    Article  PubMed  CAS  Google Scholar 

  • Werk EE, MacGee J, Shohton LJ. Effect of diphenylhydantoin on cortisol metabolism in man. Journal of Clinical Investigation 43: 1824–1835, 1964

    Article  PubMed  CAS  Google Scholar 

  • Werk EE, Thrasher K, Sholiton LJ, Olinger C, Choi Y. Cortisol production in epileptic patients treated with diphenylhydantoin. Clinical Pharmacology and Therapeutics 12: 698–703, 1971

    PubMed  Google Scholar 

  • Wesseling H, Mols-Thurkow I. Interaction of diphenylhydantoin (DPH) and tolbutamide in man. European Journal of Clinical Pharmacology 8: 75–78, 1975

    Article  PubMed  CAS  Google Scholar 

  • Wilcox JB. Phenytoin intoxication and cotrimoxazole. New Zealand Medical Journal 94: 235–236, 1981

    PubMed  CAS  Google Scholar 

  • Wilder BJ, Willmore U, Bruni J, Villarreal HJ. Valproic acid: interaction with other anticonvulsant drugs. Neurology 28: 892–896, 1978

    Article  PubMed  CAS  Google Scholar 

  • Wilensky AJ, Friel PN, Ojemann LM, Kupferberg HJ, Levy RH. Pharmacokinelics of W-554 (ADD 0355) in epileptic patients. Epilepsia 26: 602–606, 1985

    Article  PubMed  CAS  Google Scholar 

  • Wilkinson GR, Shand DG. A physiological approach to hepatic drug clearance. Clinical Pharmacology and Therapeutics 18: 377–390, 1975

    PubMed  CAS  Google Scholar 

  • Williams K, Begg E, Wade D, O’Shea K. Effects of phenytoin, phenobarbital, and ascorbic acid on misonidazole elimination. Clinical Pharmacology and Therapeutics 33: 314–321, 1983

    Article  PubMed  CAS  Google Scholar 

  • Williams KM. Kinetics of misonidazole enantiomers. Clinical Pharmacology and Therapeutics 36: 817–823, 1984

    Article  PubMed  CAS  Google Scholar 

  • Windorfer A, Sauer W. Drug interactions during anticonvulsant therapy in childhood: diphenylhydantoin, primidone, phenobarbitone, clonazepam, nitrazepam, carbamazepine and dipropylacelate. Neuropediatrie 8: 29–41, 1977

    Article  Google Scholar 

  • Winter ME, Tozer TN. Phenytoin. in Evans et al. (Eds) Applied pharmacokinetics. Principles of therapeutic drug monitoring. 2nd ed., pp. 493–539, Applied Therapeutics Inc., Spokane, 1986

    Google Scholar 

  • Wolff J, Standaert ME, Rail JE. Thyroxine displacement from serum proteins and depression of serum protein-bound iodine by certain drugs. Journal of Clinical Investigation 40: 1373–1379, 1961

    Article  PubMed  CAS  Google Scholar 

  • Wong DD, Longenecker RG, Licpman M, Baker S, LaVergne M. Phenytoin-dexamethasone: a possible drug-drug interaction. Journal of the American Medical Association 254: 2062–2063, 1985

    Article  PubMed  CAS  Google Scholar 

  • Worden JP, Wood CA, Workman CH. Phenytoin and nasogastric feedings. Neurology 34: 132, 1984

    Article  PubMed  Google Scholar 

  • Workman P, Bleehen NM, Wiltshire CR. Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: Implications for possible reduced toxicily. British Journal of Cancer 41: 302–304, 1980

    Article  PubMed  CAS  Google Scholar 

  • Yokochi K, Yokochi A, Chiba K, Ishizaki T. Phenyloin-allopurinol interaction: Michaelis-Menten kinetic parameters of phenytoin with and without allopurinol in a child with Lesch-Nyhan syndrome. Therapeutic Drug Monitoring 4: 353–357, 1982

    Article  PubMed  CAS  Google Scholar 

  • Yuen GJ. Interaction of phenytoin and folic acid: an alternate explanation. Clinical Pharmacy 3: 116, 1984

    PubMed  CAS  Google Scholar 

  • Zielinski JJ, Haidukewych D. Dual effects of carbamazepinephenytoin interaction. Therapeutic Drug Monitoring 9: 21–23, 1987

    Article  PubMed  CAS  Google Scholar 

  • Zielinski JJ, Haidukewych D, Leheta BJ. Carbamazepine-pheny-toin interaction: Elevation of plasma phenytoin concentrations due to carbamazepine comedication. Therapeutic Drug Monitoring 7: 51–53, 1985

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Pharmacy, South Australian Institute of Technology, North Terrace, Adelaide, 5000, Australia

    Roger L. Nation, Allan M. Evans & Robert W. Milne

Authors
  1. Roger L. Nation
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Allan M. Evans
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert W. Milne
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nation, R.L., Evans, A.M. & Milne, R.W. Pharmacokinetic Drug Interactions with Phenytoin (Part II). Clin Pharmacokinet 18, 131–150 (1990). https://doi.org/10.2165/00003088-199018020-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-199018020-00004

Keywords

Search

Navigation